Endo reports positive cellulite treatment data on XiaflexBy MediJune 16, 2024 Endo International plc ENDP announced positive data from a phase IIb study of Xiaflex (clostridium histolyticum collagenase) for the treatment of patients suffering from fibrosclerotic pannicopathy,…